The death toll from Lassa fever in Nigeria has risen to 53 according to the latest situation report of the disease obtained from the Nigeria Centre for Disease Control on Thursday.The situation report ...
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing next generation immunotherapeutics based on its proprietary arenavirus platform. The company’s ...
The Nigeria Centre for Disease Control and Prevention has confirmed 143 cases of Lassa fever out of the 484 suspected cases from December 30, 2024, to January 12, 2025, in seven states across 32 local ...
The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel ...